Heart failureindicated to reduce the risk of cardiovascular death and hospitalization for heart failure (hf) in patients with chronic heart failure (chf) (nyha class ii-iv) and reduced ejection fraction.recommended starting dose: 49 mg/51 mg po bidtarget maintenance dose: after 2-4 weeks, double the dose to the target maintenance dose of 97 mg/103 mg po bid as tolerated
المزيد من التفاصيل